Skip to content
value.today

Joincare Pharmaceutical Group Industry Co., Ltd.

600380.SS
$3.1 Blast known market cap, Mar 2026 — no current value
Compare
World rank
—
no current market cap
Revenue
$2.3 B
Dec-2021 ending year
value.today research
Net income
$193 M
8.3% margin
value.today research
Employees
13,000
As on 2019
value.today research

Joincare Pharmaceutical Group Industry Co., Ltd. in brief

Joincare Pharmaceutical Group Industry Co., Ltd. is a listed company in the Pharmaceutical industry, based in China. Its last known market value was $3.1 B (March 2026); there is no current figure. In the year to Dec 2021 it had sales of $2.3 B and a net profit of $193 M, about 8 cents of profit for every dollar of sales. It employs about 13,000 people. Its shares trade under the symbol 600380.SS (Shanghai).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Joincare Pharmaceutical Group Industry Co., Ltd.

Joincare Pharmaceutical Group Industry is an integrative business of Joincare includes invention, manufacture, selling and service of healthcare product company focus on building technology platforms such as monoclonal antibody, inhaled preparation, long term sustained release microspheres and nano lipid micro emulsion etc. The company annual revenue is 2.05 billion USD and 13,000 employee as on 2020. The headquarters is in China.

Market cap history

$0 M$1.1 B$2.2 B$3.4 B$4.5 B2020202120222023202420252026

World rank over time

▲ up 2,218 places since 2020
2020-01-01: #4099#4,09920202021-01-01: #3406#3,40620212022-01-07: #3888#3,88820222022-12-25: #3981#3,98120222023-07-30: #3923#3,92320232024-01-05: #4079#4,07920242026-03-08: #1881#1,8812026

Rank in China: #708 (Jan 2020) · #629 (Jan 2021) · #769 (Jan 2022) · #771 (Dec 2022) · #687 (Jul 2023) · #669 (Jan 2024) · #923 (Mar 2026)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
8.3%
Operating margin
—
Return on equity
6.6%
Liabilities / assets
35.1%
Revenue per employee
$178 K
Profit per employee
$15 K

Annual results

Revenue
$2.3 B
Operating income
—
Net income
$193 M

Dec-2021 ending year

Balance sheet

Total assets
$4.5 B
Total liabilities
$1.6 B
Total equity
$2.9 B

Dec-2021 ending year

Mutual funds holding Joincare Pharmaceutical Group Industry Co., Ltd.#

17 funds in 2 countries hold shares worth $8 M. Since their previous reports 1 added shares and 7 sold, selling $1 M net. By country: USA 16 ($7 M), Sweden 1 ($1 M).
Mutual funds holding Joincare Pharmaceutical Group Industry Co., Ltd.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.1.87 M$3 M—<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc.1.68 M$3 M—<0.01%no changeJul 31, 2026
🇸🇪 Handelsbanken Global Index CriteriaHandelsbanken Fonder AB688,720$1 M—0.01%no changeJun 30, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Index FundThe Vanguard Group, Inc.339,200$1 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP219,500$0 M—<0.01%−24%Jul 31, 2026
🇺🇸 Schwab Emerging Markets Equity ETFCharles Schwab Investment Management, Inc.175,700$0 M—<0.01%no changeMay 31, 2026
🇺🇸 JPMorgan Diversified Return Emerging Markets Equity ETFJ.P. Morgan Investment Management Inc.168,000$0 M—0.07%no changeJul 31, 2026
🇺🇸 State Street SPDR S&P China ETFSSGA Funds Management, Inc.96,504$0 M—0.03%−4.0%Jun 30, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.48,000$0 M—<0.01%no changeJul 31, 2026
🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc.27,600$0 M—<0.01%+7.8%Jun 30, 2026
🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP24,700$0 M—0.01%no changeJul 31, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.18,700$0 M—<0.01%no changeMay 31, 2026
🇺🇸 SA Emerging Markets Value FundFocus Advisor Solutions, LLC18,700$0 M—0.01%no changeJun 30, 2026
🇺🇸 Franklin FTSE China ETFFranklin Advisory Services, LLC18,300$0 M—0.01%−1.6%Jun 30, 2026
🇺🇸 Dimensional World ex U.S. Sustainability Targeted Value PortfolioDimensional Fund Advisors LP7,100$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Goldman Sachs MarketBeta Total International Equity ETFGoldman Sachs Asset Management, L.P.1,787$0 M—<0.01%no changeMay 29, 2026
🇺🇸 Goldman Sachs MarketBeta Emerging Markets Equity ETFGoldman Sachs Asset Management, L.P.1,040$0 M—<0.01%−2.4%May 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 17 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Joincare Pharmaceutical Group Industry Co., Ltd. operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Joincare Pharmaceutical Group Industry Co., Ltd.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Joincare Pharmaceutical Group Industry Co., Ltd.: countries of operation
CountryPresenceRevenue there
🇨🇳 ChinaHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

How Joincare Pharmaceutical Group Industry Co., Ltd. compares in Pharmaceutical

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Joincare Pharmaceutical Group Industry Co., Ltd.🇨🇳$3.1 B—8.3%—
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Mar 8, 2026 (last known)
Annual results:
Dec-2021 ending year
Balance sheet:
Dec-2021 ending year
Employees:
As on 2019
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Joincare Pharmaceutical Group Industry Co., Ltd.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Joincare Pharmaceutical Group Industry Co., Ltd.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Joincare Pharmaceutical Group Industry Co., Ltd.? Suggest a correction